Yoga for Solid Tumor
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03728205 |
Recruitment Status :
Withdrawn
(Covid-19)
First Posted : November 2, 2018
Last Update Posted : April 27, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Solid Tumor, Adult | Behavioral: Yoga | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | A Pilot Study On The Effect Of Yoga On Fatigue, And Stress Levels In Solid Tumor Cancer Patients Undergoing Active Radiation Therapy |
Actual Study Start Date : | December 15, 2018 |
Actual Primary Completion Date : | December 31, 2020 |
Actual Study Completion Date : | January 14, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Observational
All 10 pilot subjects will be taking yoga
|
Behavioral: Yoga
Twice weekly yoga sessions for 12 weeks |
- The feasibility of implementing Eischens yoga interventions for solid tumor cancer patients undergoing radiation therapy. This will be measured by the success rate of recruitment and retention for 10 subjects. [ Time Frame: 12 months ]Feasibility
- Effects on fatigue [ Time Frame: 12 months ]Examine the effect of yoga on cancer and radiation related fatigue during radiation therapy. We will use the BFI results both before, during and after radiation therapy.
- Effects on Stress Level [ Time Frame: 12 Months ]Examine the effect of yoga on cancer and radiation related fatigue during radiation therapy. We will use the NCCN Distress thermometer results both before, during and after radiation therapy.
- Long Term [ Time Frame: 17 months ]Examine the long term effect of yoga to be tested at the 6 months post radiation visit. We will use the BFI and distress thermometer to see if any positive results during yoga are sustained to the 6 month follow up visit.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Stage I and II Cancer patients with solid tumors undergoing RT for 4-8 weeks (external beam radiation).
- Patients of age >18, and all races will be included in the study.
- All patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Pennsylvania.
- Patients must be English speaking.
-
Patients must be able to attend the schedule classes.
Exclusion Criteria:
- Patients with medical restrictions that may interfere with or prevent them from taking part in the yoga interventions per their physician orders.
- Patients with metastatic disease.
- Active smokers. Smoking may interfere with relaxation and breathing modalities of the yoga interventions. (Self-reporting smokers that have been smoke free for 6 months may be included)
- Patients who currently practice or have recently practiced yoga (had not taken a yoga class on a regular bases in the last 6 months).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03728205
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 |
Responsible Party: | Abramson Cancer Center of the University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT03728205 |
Other Study ID Numbers: |
UPCC 13918 831417 ( Other Identifier: Penn Medicine ) |
First Posted: | November 2, 2018 Key Record Dates |
Last Update Posted: | April 27, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Neoplasms |